About: Tengion

An Entity of Type: Public company, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Tengion, Inc. is an American development-stage regenerative medicine company founded in 2003 with financing from J&J Development Corporation, HealthCap and Oak Investment Partners, which is headquartered in Winston-Salem, North Carolina. Its goals are discovering, developing, manufacturing and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues, to address unmet medical needs in urologic, renal, gastrointestinal, and vascular diseases and disorders. The company creates these human neo-organs from a patient’s own cells or autologous cells, in conjunction with its Organ Regeneration Platform. The company declared Chapter 7 bankruptcy in December 2014, and it, along with its assets and tissue engineering samples, have been bought back by its creditors and

Property Value
dbo:abstract
  • Tengion, Inc. is an American development-stage regenerative medicine company founded in 2003 with financing from J&J Development Corporation, HealthCap and Oak Investment Partners, which is headquartered in Winston-Salem, North Carolina. Its goals are discovering, developing, manufacturing and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues, to address unmet medical needs in urologic, renal, gastrointestinal, and vascular diseases and disorders. The company creates these human neo-organs from a patient’s own cells or autologous cells, in conjunction with its Organ Regeneration Platform. The company declared Chapter 7 bankruptcy in December 2014, and it, along with its assets and tissue engineering samples, have been bought back by its creditors and former executives as of March 2015. The purchase was expedited, so that time-sensitive research can continue. (en)
dbo:foundingYear
  • 2003-01-01 (xsd:gYear)
dbo:keyPerson
dbo:numberOfEmployees
  • 25 (xsd:nonNegativeInteger)
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 36772719 (xsd:integer)
dbo:wikiPageLength
  • 7477 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1106782028 (xsd:integer)
dbo:wikiPageWikiLink
dbp:foundation
  • 2003 (xsd:integer)
dbp:industry
  • Biotechnology (en)
dbp:keyPeople
  • A. Brian Davis (en)
  • David I. Scheer (en)
  • John L. Miclot (en)
  • Timothy A. Bertram DVM, PhD (en)
dbp:locationCity
dbp:locationCountry
dbp:name
  • Tengion, Inc. (en)
dbp:numEmployees
  • 25 (xsd:integer)
dbp:type
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Tengion, Inc. is an American development-stage regenerative medicine company founded in 2003 with financing from J&J Development Corporation, HealthCap and Oak Investment Partners, which is headquartered in Winston-Salem, North Carolina. Its goals are discovering, developing, manufacturing and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues, to address unmet medical needs in urologic, renal, gastrointestinal, and vascular diseases and disorders. The company creates these human neo-organs from a patient’s own cells or autologous cells, in conjunction with its Organ Regeneration Platform. The company declared Chapter 7 bankruptcy in December 2014, and it, along with its assets and tissue engineering samples, have been bought back by its creditors and (en)
rdfs:label
  • Tengion (en)
owl:sameAs
skos:closeMatch
prov:wasDerivedFrom
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Tengion, Inc. (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License